+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Transdermal Skin Patches Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis

  • PDF Icon

    Report

  • 115 Pages
  • April 2022
  • Region: Global
  • Renub Research
  • ID: 5576807
Global Transdermal Skin Patches Market is expected to reach US$ 9.6 Billion in 2027. Transdermal skin patches are a non-invasive and simple means of delivering steady and consistent therapeutic doses into the bloodstream over a set period. Backings, medicines, membranes, adhesives, liners, chemical enhancers and permeates, physical assistance, and low electrical current techniques such as iontophoresis are among them. Depending on the skin's properties and the patch's design, they provide a uniform diffusion rate. They are currently widely utilized worldwide as cosmetic, topical, and transdermal delivery systems.



The primary factors driving the transdermal skin patches market expansion are the rising benefits of transdermal medicine over oral and swallowing drugs (medications for gastrointestinal toxicity) that cause nausea and vomiting. They are less inconvenient than intravenous or parenteral therapies since they are non-invasive. The key benefit is that the patch allows for regulated drug release to the patient, usually accomplished by a perforated membrane covering the drug reservoir or by body warmth dissolving small layers of medication in the adhesive.

COVID-19 Outbreak Boosted the Transdermal Patch Market Size:


The COVID-19 outbreak has likely had a beneficial effect on the market for transdermal skin patches. These patches make it possible to administer medications to a specific skin microenvironment safely, repeatable, and regulated manner. As a result, researchers working on a potential COVID-19 vaccination were looking into using a fingertip-sized skin patch to deliver the vaccine. According to the publisher, Global Transdermal Skin Patches Market Is Foreseen to Register a CAGR of 3.52% during 2021-2027.

Worldwide Transdermal Skin Patches Market Size was US$ 7.8 Billion in 2021


The transdermal skin patches market is split by Type and Application in the analysis. Furthermore, the growth of these segments assists in the study of the industries' meagre growth. It provides a vital market overview and industry insights to aid in strategic decision-making to identify core market applications.

By Types, the Transdermal Skin Patches Market is divided into three types: Single Layer Drug Adhesive, Multi-Layer Drug Adhesive, and Matrix.

By Application, the Transdermal Skin Patches Market is divided into four categories: Pain Management, Hormonal Application, Central Nervous System Disorder, and Cardiovascular Diseases.

Transdermal Skin Patches Market Regional Level Analysis:


North America, Asia Pacific, Europe, and Rest of World are the critical regions in the transdermal skin patches market study. According to the research, North America dominates the transdermal patches market due to the increasing presence of key players and established healthcare infrastructure, increasing beneficial government initiatives, increasing the number of research partnerships, increasing the adoption of various strategies such as product innovation, and increasing product launches and approval in this region.

Competitive Landscape:


The market for transdermal skin patches is competitive. Leading companies focus on product innovations, product launches and approvals, R&D investment for advancements in transdermal patches, and mergers and acquisitions as developmental strategies to stay competitive in the industry. Teva Pharmaceutical Industries Ltd, Novartis AG, Mylan NV (Viatris), Luye Pharma Group, Bayer HealthCare Pharmaceuticals, Allergan, 3M Health Care Business Group, and Henan Lingrui Pharmaceutical Ltd are some of the key players in the market.

The publisher's latest report Transdermal Skin Patches Market, Global Forecast By Type (Single Layer Drug Adhesive, Multi-Layer Drug Adhesive, and Matrix), Application (Pain Management, Hormonal Application, Central Nervous System Disorder, and Cardiovascular Diseases), Region (North America, Asia Pacific, Europe, and ROW), Companies (Teva Pharmaceutical Industries Ltd, Novartis AG, Mylan NV (Viatris), Luye Pharma Group, Bayer HealthCare Pharmaceuticals, Allergan, 3M Health Care Business Group, and Henan Lingrui Pharmaceutical Ltd)” provides a detailed analysis of Transdermal Skin Patches Industry.

Type - Market has been covered from 4 viewpoints:


1. Single Layer Drug Adhesive
2. Multi-Layer Drug Adhesive
3. Matrix
4. Others

Application - Market has been covered from 5 viewpoints:


1. Pain Management
2. Hormonal Application
3. Central Nervous System Disorder
4. Cardiovascular Diseases
5. Others

Regions - Market has been covered from 4 viewpoints:


1. North America
2. Asia Pacific
3. Europe
4. Rest of World

Company Insights:


  • Company Profile
  • Recent Developments
  • Revenue

Companies Covered:


1. Teva Pharmaceutical Industries Ltd
2. Novartis AG
3. Mylan NV (Viatris)
4. Luye Pharma Group
5. Bayer HealthCare Pharmaceuticals
6. Allergan
7. 3M Health Care Business Group
8. Henan lingrui pharmaceutical ltd
Frequently Asked Questions about the Global Transdermal Skin Patches Market

What is the estimated value of the Global Transdermal Skin Patches Market?

The Global Transdermal Skin Patches Market was estimated to be valued at $7.8 Billion in 2021.

What is the growth rate of the Global Transdermal Skin Patches Market?

The growth rate of the Global Transdermal Skin Patches Market is 3.5%, with an estimated value of $9.6 Billion by 2027.

What is the forecasted size of the Global Transdermal Skin Patches Market?

The Global Transdermal Skin Patches Market is estimated to be worth $9.6 Billion by 2027.

Who are the key companies in the Global Transdermal Skin Patches Market?

Key companies in the Global Transdermal Skin Patches Market include Teva Pharmaceutical Industries Ltd, Novartis AG, Mylan NV (Viatris), Luye Pharma Group, Bayer HealthCare Pharmaceuticals, Allergan and Henan lingrui pharmaceutical ltd.

Table of Contents

1. Introduction2. Research Methodology3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Transdermal Skin Patch Market
6. Market Share
6.1 By Type
6.2 By Application
6.3 By Regions
7. Type - Global Transdermal Skin Patches Market
7.1 Single Layer Drug Adhesive
7.2 Multi-Layer Drug Adhesive
7.3 Matrix
7.4 Others
8. Application - Global Transdermal Skin Patches Market
8.1 Pain Management
8.2 Hormonal Application
8.3 Central Nervous System Disorder
8.4 Cardiovascular Diseases
8.5 Others
9. Regions - Global Transdermal Skin Patches Market
9.1 North America
9.2 Asia Pacific
9.3 Europe
9.4 Rest of World
10. Porters Five Forces
10.1 Bargaining Power of Buyers
10.2 Bargaining Power of Suppliers
10.3 Degree of Competition
10.4 Threat of New Entrants
10.5 Threat of Substitutes
11. Company Analysis
11.1 Teva Pharmaceutical Industries Ltd
11.1.1 Company Profile
11.1.2 Recent Developments
11.1.3 Revenue
11.2 Novartis AG
11.2.1 Company Profile
11.2.2 Recent Developments
11.2.3 Revenue
11.3 Mylan NV (Viatris)
11.3.1 Company Profile
11.3.2 Recent Developments
11.3.3 Revenue
11.4 Luye Pharma Group
11.4.1 Company Profile
11.4.2 Recent Developments
11.4.3 Revenue
11.5 Bayer HealthCare Pharmaceuticals
11.5.1 Company Profile
11.5.2 Recent Developments
11.5.3 Revenue
11.6 Allergan
11.6.1 Company Profile
11.6.2 Recent Developments
11.6.3 Revenue
11.7 3M Health Care Business Group
11.7.1 Company Profile
11.7.2 Recent Developments
11.7.3 Revenue
11.8 Henan lingrui pharmaceutical ltd
11.8.1 Company Profile
11.8.2 Recent Developments
11.8.3 Revenue
List of Figures:
Figure 01: Global - Transdermal Skin Patch Market (Billion US$), 2017 - 2021
Figure 02: Global - Forecast for Transdermal Skin Patch Market (Billion US$), 2022 - 2027
Figure 03: Type - Single Layer Drug Adhesive Market (Million US$), 2017 - 2021
Figure 04: Type - Forecast for Single Layer Drug Adhesive Market (Million US$), 2022 - 2027
Figure 05: Type - Multi-Layer Drug Adhesive Market (Million US$), 2017 - 2021
Figure 06: Type - Forecast for Multi-Layer Drug Adhesive Market (Million US$), 2022 - 2027
Figure 07: Type - Matrix Market (Million US$), 2017 - 2021
Figure 08: Type - Forecast for Matrix Market (Million US$), 2022 - 2027
Figure 09: Type - Others Market (Million US$), 2017 - 2021
Figure 10: Type - Forecast for Others Market (Million US$), 2022 - 2027
Figure 11: Application - Pain Management Market (Million US$), 2017 - 2021
Figure 12: Application - Forecast for Pain Management Market (Million US$), 2022 - 2027
Figure 13: Application - Hormonal Application Market (Million US$), 2017 - 2021
Figure 14: Application - Forecast for Hormonal Application Market (Million US$), 2022 - 2027
Figure 15: Application - Central Nervous System Disorder Market (Million US$), 2017 - 2021
Figure 16: Application - Forecast for Central Nervous System Disorder Market (Million US$), 2022 - 2027
Figure 17: Application - Cardiovascular Diseases Market (Million US$), 2017 - 2021
Figure 18: Application - Forecast for Cardiovascular Diseases Market (Million US$), 2022 - 2027
Figure 19: Application - Others Market (Million US$), 2017 - 2021
Figure 20: Application - Forecast for Others Market (Million US$), 2022 - 2027
Figure 21: North America - Transdermal Skin Patch Market (Million US$), 2017 - 2021
Figure 22: North America - Forecast for Transdermal Skin Patch Market (Million US$), 2022 - 2027
Figure 23: Asia Pacific - Transdermal Skin Patch Market (Million US$), 2017 - 2021
Figure 24: Asia Pacific - Forecast for Transdermal Skin Patch Market (Million US$), 2022 - 2027
Figure 25: Europe - Transdermal Skin Patch Market (Million US$), 2017 - 2021
Figure 26: Europe - Forecast for Transdermal Skin Patch Market (Million US$), 2022 - 2027
Figure 27: Rest of World - Transdermal Skin Patch Market (Million US$), 2017 - 2021
Figure 28: Rest of World - Forecast for Transdermal Skin Patch Market (Million US$), 2022 - 2027
Figure 29: Teva Pharmaceutical Industries Ltd - Global Revenue (Million US$), 2017 - 2021
Figure 30: Teva Pharmaceutical Industries Ltd - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 31: Novartis AG - Global Revenue (Million US$), 2017 - 2021
Figure 32: Novartis AG - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 33: Mylan NV (Viatris) - Global Revenue (Million US$), 2017 - 2021
Figure 34: Mylan NV (Viatris) - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 35: Luye Pharma Group - Global Revenue (Million US$), 2017 - 2021
Figure 36: Luye Pharma Group - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 37: Bayer HealthCare Pharmaceuticals - Global Revenue (Million US$), 2017 - 2021
Figure 38: Bayer HealthCare Pharmaceuticals - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 39: Allergan - Global Revenue (Million US$), 2017 - 2021
Figure 40: Allergan - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 41: 3M Health Care Business Group - Global Revenue (Million US$), 2017 - 2021
Figure 42: 3M Health Care Business Group - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 43: Henan lingrui pharmaceutical ltd - Global Revenue (Million US$), 2017 - 2021
Figure 44: Henan lingrui pharmaceutical ltd - Forecast for Global Revenue (Million US$), 2022 - 2027
List of Tables:
Table 01: Global - Transdermal Skin Patch Market Share by Type (Percent), 2017 - 2021
Table 02: Global - Forecast for Transdermal Skin Patch Market Share by Type (Percent), 2022 - 2027
Table 03: Global - Transdermal Skin Patch Market Share by Application (Percent), 2017 - 2021
Table 04: Global - Forecast for Transdermal Skin Patch Market Share by Application (Percent), 2022 - 2027
Table 05: Global - Transdermal Skin Patch Market Share by Region (Percent), 2017 - 2021
Table 06: Global - Forecast for Transdermal Skin Patch Market Share by Region (Percent), 2022 - 2027

Companies Mentioned

  • Teva Pharmaceutical Industries Ltd
  • Novartis AG
  • Mylan NV (Viatris)
  • Luye Pharma Group
  • Bayer HealthCare Pharmaceuticals
  • Allergan
  • 3M Health Care Business Group
  • Henan lingrui pharmaceutical ltd

Methodology

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...